Daniel C. Brocks, MD, BostonSight chief medical officer, discusses a few of the company's studies, the patients they serve, and what the broader eye care community may be missing.
BostonSight
Latest Content
With this expansion, BostonSight reinforces its commitment to advancing care for patients with severe ocular surface disease and irregular corneas.
Enhanced scleral lens design and order management platform for practitioners provides exceptional user experience.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Epion Therapeutics completes phase 3 trials of EpiSmart epithelium-on cross-linking for keratoconus
2
Euclid Vision receives FDA clearance for Be Free Day toric contact lenses
3
Sparkling retina: Multimodal imaging in Bietti crystalline dystrophy
4
Oculis enrolls first patient in licaminlimab PREDICT-1 DED trial
5